Acral lentiginous melanoma shows a poorer response to immune checkpoint inhibition in the non-resectable or metastatic setting – A EUMelaReg real world outcome study

to differentiate true progression from pseudoprogression.Further research should focus on identifying biomarkers to guide therapy for patients with oligoprogressive disease.

Authors

Institutions

Publication Details

Journal
EJC Skin Cancer
Published
2025-01-01
DOI
https://doi.org/10.1016/j.ejcskn.2025.100527
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Acral lentiginous melanoma shows a poorer response to immune checkpoint inhibition in the non-resectable or metastatic setting – A EUMelaReg real world outcome study

Lara Valeska Maul, Nethanel Asher, Claudia Pföhler, E. Espinosa et al.
1 citations
EJC Skin Cancer
Cancer Immunotherapy and Biomarkers
1.05
article

Acral lentiginous melanoma shows a poorer response to immune checkpoint inhibition in the non-resectable or metastatic setting – A EUMelaReg real world outcome study

Lara Valeska Maul, Nethanel Asher, Claudia Pföhler, E. Espinosa, P. Terheyden, Katharina C. Kähler, Dirk Schadendorf, Inga Marijanović, M. Weichenthal, Peter Mohr, Dimitriοs Ziogas, P. Teterycz, P. Rutkowski, I. Márquez-Rodas, I. Gavrilova, P.A. Ascierto, Mirna Šitum, Omar Hasan Ali, S. Grynberg, Teresa Puértolas Hernández, Anne Zaremba, J. Mangana, Shahar Lev‐Ari, M. Bender, Helen J Gogas, B. Dujović, P. Ayala de Miguel, Lidija Kandolf, Maria Grazia Vitale, A. Kontilev
article en
1 citations

Abstract

to differentiate true progression from pseudoprogression.Further research should focus on identifying biomarkers to guide therapy for patients with oligoprogressive disease.

EJC Skin CancerVol. 3
Military Medical Academy (RS), National and Kapodistrian University of Athens (GR), University Clinical Hospital Mostar (BA), Sheba Medical Center (IL), Tokuda Hospital (BG), Rabin Medical Center (IL), Hospital Universitario La Paz (ES), Hospital General Universitario Gregorio Marañón (ES), Christian-Albrechts-Universität zu Kiel (DE), Acibadem City Clinic (BG), University Hospital of Zurich (CH), Hospital San Pedro de Alcántara (ES), University Hospital Schleswig-Holstein (DE), National Heart Hospital (BG), Hospital Universitario Miguel Servet (ES), Essen University Hospital (DE), Sisters of Charity Hospital (HR), Elbe Kliniken Stade-Buxtehude (DE), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Saarland University (DE), University of Lübeck (DE)
No poverty
Openalex Percentile: Top 24%
Cancer Immunotherapy and Biomarkers
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.